A detailed history of Bank Of America Corp transactions in Journey Medical Corp stock. As of the latest transaction made, Bank Of America Corp holds 82 shares of DERM stock, worth $450. This represents 0.0% of its overall portfolio holdings.

Number of Shares
82
Previous 71 15.49%
Holding current value
$450
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$4.22 - $5.91 $46 - $65
11 Added 15.49%
82 $0
Q2 2024

Aug 14, 2024

SELL
$3.31 - $5.94 $74,756 - $134,154
-22,585 Reduced 99.69%
71 $0
Q1 2024

May 15, 2024

BUY
$2.92 - $5.47 $65,653 - $122,987
22,484 Added 13072.09%
22,656 $83,000
Q4 2023

Feb 14, 2024

BUY
$2.7 - $7.96 $464 - $1,369
172 New
172 $0
Q4 2022

Feb 10, 2023

BUY
$1.14 - $2.85 $15 - $39
14 New
14 $0

Others Institutions Holding DERM

About Journey Medical Corp


  • Ticker DERM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 11,596,500
  • Market Cap $63.7M
  • Description
  • Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat...
More about DERM
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.